Evolving Diagnostic and Treatment Landscape of Lower-Grade Gliomas
Dr. Patrick Wen shares his expert insights about current diagnostic criteria and the evolving landscape of novel therapies for the treatment of these tumors.
Patrick Wen discloses the following relationships:
Grant/Research/Clinical Trial Support: Agios, Astra Zeneca, Bayer, Blue Earth Diagnostics , Immunomic Therapeutics, Karyopharm, Kiyatec, Puma, Taiho, Vascular Bigenics, Deciphera, VBI Vaccines
Speaker’s Bureau Consultant/Advisory Boards: Merck, Prime Oncology, Roche [Brain Tumor] Avastin, Agios Pharmaceuticals Inc, Bayer, Blue Earth Diagnostics, Karyopharm, Kiyatec, Deciphera, VBI Vaccines, Puma, Astra Zeneca, Immunomic Therapeutics, Vascular Biogenics, Taiho Oncology